Neuraxpharm and mjn-neuro to Launch AI Wearable for Early Seizure Detection
Neuraxpharm and mjn-neuro announced in a press release plans to launch EPISERAS, a digital health solution that uses artificial intelligence to predict the risk of epileptic seizures in real time.
EPISERAS is a non-invasive medical device that continuously records brain activity through a discreet earpiece sensor. The system analyses electrical patterns in the brain using AI algorithms to identify when a seizure is likely to occur and sends alerts minutes in advance when the risk is high.
The device connects to a mobile application that displays seizure-risk data and notifications for patients and caregivers. It is designed for individuals with drug-resistant epilepsy, providing a proactive monitoring tool to improve safety in daily life.
EPISERAS has received CE and UKCA certification as a Class IIa medical device in Europe. A multicentre clinical study, SERAS-Home_RWD, is currently being conducted across Spain, the UK, and Germany to further validate the technology.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Machine-learning models predict death risk after heart attack better than standard score Nov 13 Redesign Health launches growth equity practice for clinical AI Nov 13 Dyania Health and Nvidia bring clinical reasoning AI inside hospital networks Nov 13 Betterness extends seed round to $3.5M for Miami AI health networks Nov 13 93% of health systems now use AI, CHIME survey findsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Kardi AI Raises €5.3 Million for Heart Monitoring Expansion
Helfie AI and Health Innovation South West to Test Smartphone Hypertension Screening
BRAINIAC hub receives £20 million for AI dementia clinics
Peri wearable joins TIME's Best Inventions of 2026
Masimo Gets FDA Clearance for AFib Detection on Radius VSM
Daily AI Brief: the AI news that matters, in your inbox.